INS and Impaired glucose tolerance: Liver-specific H19 overexpression by administration of AAV-H19 that expressed mouse full-length H19 elevated both the fasting blood glucose and fasting blood insulin levels, impaired glucose tolerance, promoted IR and augmented hepatic glucose production as assessed by glucose-tolerance tests, insulin-tolerant tests and pyruvate tolerance tests, respectively.